Anew Labs
An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.
$290MFunding
Lead5C
5Y Capital
Activity from announced rounds
Activity in this selectionimc-456dc02f
- Rounds participated in
- 4
- Confirmed lead rounds
- 1 3 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $497.7M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionSyneron Bio
Develops intelligent platform-driven macrocyclic peptide drug discovery
$150MSeries B
Role not disclosedExcalipoint Therapeutics
Develops next-generation T-cell engager therapies for cancer and autoimmune diseases
$27.7MSeed+
Role not disclosedDify
Helps teams build deploy and operate production-grade AI applications and agentic workflows
$30MPre-Series A
Role not disclosed